Sandra Cristea

2.8k total citations · 1 hit paper
9 papers, 1.5k citations indexed

About

Sandra Cristea is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sandra Cristea has authored 9 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandra Cristea's work include Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Mechanisms and Therapy (2 papers). Sandra Cristea is often cited by papers focused on Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Mechanisms and Therapy (2 papers). Sandra Cristea collaborates with scholars based in United States, France and Germany. Sandra Cristea's co-authors include Julien Sage, Lauren A. Byers, Triparna Sen, Bonnie S. Glisson, Jing Wang, Lerong Li, Don L. Gibbons, John V. Heymach, Junya Fujimoto and Yongbin Yang and has published in prestigious journals such as Nature, Molecular Cell and PLoS ONE.

In The Last Decade

Sandra Cristea

9 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

2019 616 citations Triparna Sen, B. Leticia Rodriguez et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Cristea United States	8	906	898	344	297	207	9	1.5k
Montaser Shaheen United States	20	736 0.8×	862 1.0×	400 1.2×	119 0.4×	122 0.6×	60	1.5k
Annan Yang United States	11	1.5k 1.6×	633 0.7×	179 0.5×	496 1.7×	223 1.1×	20	2.0k
Ángel García-Díaz Spain	13	929 1.0×	1.2k 1.4×	947 2.8×	107 0.4×	245 1.2×	24	2.2k
Damian J. Junk United States	17	777 0.9×	695 0.8×	320 0.9×	81 0.3×	100 0.5×	27	1.4k
Meng Duan China	22	589 0.7×	452 0.5×	452 1.3×	165 0.6×	170 0.8×	42	1.4k
Chi-Hong Chao Taiwan	15	1.5k 1.6×	785 0.9×	208 0.6×	217 0.7×	126 0.6×	26	2.2k
Anna E. Vilgelm United States	23	773 0.9×	1.0k 1.2×	630 1.8×	84 0.3×	283 1.4×	48	1.9k
Johann S. Bergholz United States	18	681 0.8×	522 0.6×	208 0.6×	75 0.3×	193 0.9×	26	1.2k
Christopher T. Cummings United States	14	662 0.7×	316 0.4×	538 1.6×	384 1.3×	186 0.9×	28	1.4k
Suprit Gupta United States	9	525 0.6×	462 0.5×	402 1.2×	351 1.2×	110 0.5×	13	1.2k

Countries citing papers authored by Sandra Cristea

Since Specialization

Citations

This map shows the geographic impact of Sandra Cristea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Cristea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Cristea more than expected).

Fields of papers citing papers by Sandra Cristea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Cristea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Cristea. The network helps show where Sandra Cristea may publish in the future.

Co-authorship network of co-authors of Sandra Cristea

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Cristea. A scholar is included among the top collaborators of Sandra Cristea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Cristea. Sandra Cristea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Cristea, Sandra, Garry L. Coles, Daniel Hornburg, et al.. (2020). The MEK5–ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer. Cancer Research. 80(6). 1293–1303. 52 indexed citations

2.

Sen, Triparna, B. Leticia Rodriguez, Limo Chen, et al.. (2019). Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer. Cancer Discovery. 9(5). 646–661. 616 indexed citations breakdown →

3.

Topacio, Benjamin R., Evgeny Zatulovskiy, Sandra Cristea, et al.. (2019). Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein’s C-Terminal Helix. Molecular Cell. 74(4). 758–770.e4. 204 indexed citations

4.

Ponath, Paul, Daniel L. Menezes, Chin Pan, et al.. (2018). A Novel, Fully Human Anti–fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer. Clinical Cancer Research. 24(20). 5178–5189. 39 indexed citations

5.

Lim, Jing Shan, Alvaro Ibaseta, Marcus Fischer, et al.. (2017). Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature. 545(7654). 360–364. 311 indexed citations

6.

Sen, Triparna, Pan Tong, C. Allison Stewart, et al.. (2017). CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib. Cancer Research. 77(14). 3870–3884. 145 indexed citations

7.

Cristea, Sandra & Julien Sage. (2016). Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?. Journal of Thoracic Oncology. 11(8). 1233–1241. 43 indexed citations

8.

Cristea, Sandra, Yolanda Santiago, Michael C. Holmes, et al.. (2012). In vivo cleavage of transgene donors promotes nuclease‐mediated targeted integration. Biotechnology and Bioengineering. 110(3). 871–880. 136 indexed citations

9.

Cristea, Sandra, Philip D. Gregory, Fyodor D. Urnov, & Gregory J. Cost. (2011). Dissection of Splicing Regulation at an Endogenous Locus by Zinc-Finger Nuclease-Mediated Gene Editing. PLoS ONE. 6(2). e16961–e16961. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact